Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Risk of cardiovascular and hemolytic disease in G6PD-deficient patients
2008 The human tri-peptide GHK and tissue remodeling J Pept Sci Why Research Peptides All comparisons reflect general industry practices
We further evaluated emerging therapeutic strategies that target copper homeostasisincluding chelators, chaperone inhibitors, and ionophoresand critically analyzed the translational challenges they face, such as off-target effects and preclinical model limitations
Andrzej Bartke Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, United States Contribution AB, Conception and design, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents Competing interests The authors declare that no competing interests exist
The optimal therapeutic approach may depend on the specific clinical indication, individual patient factors, availability of different treatment options, and the regulatory framework within the practicing jurisdiction
Anderson, Dennis P
US$ 26.19
US$ 29.88
US$ 24.98
US$ 27.72
US$ 29.44
US$ 24.60
